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CCAAT-enhancer binding proteins (C/EBPs) are
transcription factors that play a central role in the
differentiation of myeloid cells and adipocytes. Trib-
bles pseudokinases govern levels of C/EBPs by
recruiting them to the COP1 ubiquitin ligase for ubiq-
uitination. Here, we present the first crystal structure
of a Tribbles protein, which reveals a catalytically
inactive TRIB1 pseudokinase domain with a unique
adaptation in the aC helix. A second crystal structure
and biophysical studies of TRIB1 with its C-terminal
extension, which includes the COP1-binding motif,
show that the C-terminal extension is sequestered
at a site formed by the modified TRIB1 aC helix.
In addition, we have identified and characterized
the TRIB1 substrate-recognition sequence within
C/EBPa, which is evolutionarily conserved in C/EBP
transcription factors. Binding studies indicate that
C/EBPa recruitment is weaker in the presence of
the C-terminal COP1-binding motif, but the magni-
tude of this effect suggests that the two bind distinct
rather directly overlapping binding sites.
INTRODUCTION
Pseudokinases are kinase-like proteins that lack one or more
features critical to catalysis, and represent up to 10% of
the human kinome (Manning et al., 2002; Taylor et al., 2013).
Once considered vestigial branches of the kinome, it is now
clear that pseudokinases are critical for many facets of cellular
signaling despite their lack of enzymatic activity (Boudeau
et al., 2006; Eyers andMurphy, 2013). Human Tribbles homologs
(TRIB1, TRIB2, and TRIB3) are pseudokinases that were origi-
nally named based on their homology to the Drosophila gene,
tribbles. In flies, the tribbles gene product controls proteasomal
degradation of CDC25 phosphatases and levels of the Slbo tran-
scription factor (Mata et al., 2000; Rørth et al., 2000). Human
Tribbles homologs have been ascribed even more diverse roles,
and affect a variety of signaling, developmental, and metabolic
processes.Structure 23, 2111–21Tribbles homologs share a common domain architecture, with
a central pseudokinase domain flanked by N- and C-terminal
extensions (Figure 1A). The N-terminal extensions are not well
conserved between TRIB1, TRIB2, and TRIB3, and have been
proposed to determine protein localization based on trunca-
tion analysis (Kiss-Toth et al., 2006). In contrast, the kinase-like
domains share a large degree of sequence identity and are
indispensable for Tribbles substrate recruitment and function
(Hegedus et al., 2007; Keeshan et al., 2010). Within the C-termi-
nal tail of all three Tribbles proteins is a conserved motif that
mediates interaction with the ubiquitin E3-ligase Constitutive
Photomorphogenesis Protein 1 (COP1) (Keeshan et al., 2010;
Qi et al., 2006; Satoh et al., 2013). This motif is integral to the
proposed mode-of action of Tribbles proteins; by binding to
COP1 through their C-termini and to substrates through their
pseudokinase domains, Tribbles proteins recruit substrates to
COP1 for ubiquitination.
TRIB1, TRIB2, and TRIB3 have both shared and distinct func-
tional roles. All family members share an ability to regulate MAP
kinase signaling, either directly or indirectly (Izrailit et al., 2013;
Kiss-Toth et al., 2004; Yokoyama et al., 2012). Genome-wide as-
sociation studies have implicated TRIB1 in the regulation of liver
metabolic enzymes and plasma lipid levels (Chambers et al.,
2011; Kathiresan et al., 2008), while the ability of human TRIB3
to regulate AKT and acetyl coenzyme A (acetyl-CoA) carbox-
ylase has seen it implicated in diabetes, obesity, and atheroscle-
rosis (Du et al., 2003; Prudente et al., 2012; Qi et al., 2006). Trib1
has also recently been identified as a key determinant of tissue-
resident macrophage differentiation in mice (Akira et al., 2013;
Satoh et al., 2013). However, TRIB1 and TRIB2 appear to be
unique in their ability to regulate CCAAT-enhancer binding pro-
tein (C/EBP) transcription factors.
Slbo was one of the first Tribbles substrates identified
(Rørth et al., 2000), and is the Drosophila homolog of the human
C/EBP transcription factors. Human C/EBP family members
(C/EBPa, b, g, d, ε, and z) have broad roles in proliferation, differ-
entiation, and metabolism, particularly of hepatocytes, adipo-
cytes, and hematopoietic cells (Di Stefano et al., 2014; Ramji
and Foka, 2002; Ye et al., 2013). The central role of C/EBPs in
myeloid differentiation is illustrated by the fact that up to 10%
of acute myeloid leukemia (AML) patients have disruptive muta-
tions in C/EBPa (Nerlov, 2004). Mice transplanted with either
Trib1- or Trib2-overexpressing hematopoietic stem cells have
decreased levels of C/EBPa that is not replicated upon Trib321, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2111
AC
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Figure 1. The TRIB1 Pseudokinase Domain
(A) Schematic illustration of the conserved architecture of human Tribbles
proteins. Sequence identity within the pseudokinase domain relative to TRIB1
is indicated.
(B) Overall structure of the pseudokinase domain of TRIB1. The structures of
TRIB1(84–343) and TRIB1(84–372) are superimposed and displayed in yellow
and orange cartoon representations, respectively. The C terminal region of
TRIB1(84–372) is colored grey.
(C) The N-terminal domain of TRIB1 compared with the canonical ATP-binding
conformation of protein kinase A (PKA, cyan, PDB: 1ATP [Zheng et al., 1993]).
Top, front, and side views are shown, and are vertically aligned based on the
position of ATP (spheres). The positions of the Gly-rich loop, aC helix, and b3
strand are indicated. PKA and TRIB1 were overlaid based on the entire kinase
domain (as for Figure S1A), and the C-terminal domains are omitted from the
figure for clarity.
See also Figures S1 and S2.overexpression (Dedhia et al., 2010). Correspondingly, mice
receiving Trib1 or Trib2 overexpressing hematopoietic stem cells
developed AML with complete penetrance, whereas the Trib3
counterparts did not (Dedhia et al., 2010). In the clinical setting,
a cohort of AML patients with elevated levels of TRIB2 have
decreased levels of C/EBPa (Keeshan et al., 2006), while a
distinct subset of AML patients harbor extrachromosomal ‘‘dou-
ble-minute’’ amplifications that lead to overexpression of TRIB1
(Storlazzi et al., 2004). In contrast to Tribbles overexpression,
Trib1-deficient mice have disrupted tissue-resident macrophage
differentiation due to elevated C/EBPa levels (Satoh et al., 2013),
and dysregulated C/EBPb levels that cause aberrant responses
to toll-like receptor signaling (Yamamoto et al., 2007).
It is clear that TRIB1 and TRIB2 are important regulators
of C/EBP transcription factors and that they are apparently
distinct among the Tribbles proteins in this ability. However,
relatively little is known about the structural architecture of
Tribbles proteins or what determines specificity of Tribbles-
C/EBP interactions. Tribbles contain several sequence features
without precedent in previously characterized kinase or pseu-2112 Structure 23, 2111–2121, November 3, 2015 ª2015 Elsevier Ltddokinase proteins, which has led to conjecture over their likely
function. In particular, there remains debate about whether
the unique sequence makeup of Tribbles renders them catalyt-
ically dead. Here, we present the first structures of a Tribbles
pseudokinase, that of TRIB1, which reveal an active site that
is incompatible with ATP binding. Further functional studies
show that TRIB1 recognizes a conserved stretch within a trans-
activation domain of C/EBP proteins, and suggest a model by
which TRIB1 acts as a dynamic adapter for recruiting C/EBPs
to COP1.
RESULTS
Structure of the TRIB1 Pseudokinase Domain
The structure of the TRIB1 pseudokinase domain (residues 84–
343) was solved by single-wavelength isomorphous replace-
ment with anomalous scattering, and the native structure refined
against data to a resolution of 2.8 A˚ (Table 1). We subsequently
solved the structure of a longer fragment of TRIB1 (residues 84–
372), which comprises the core pseudokinase domain with its
intact C terminus, to significantly higher resolution (2.1 A˚). There
are only minor differences between the two structures over the
core pseudokinase domain (Figure 1B), with the activation loops
(residues 229–237) disordered in both structures. Therefore, un-
less otherwise stated we refer to the higher-resolution structure
in our presentation here.
The C-terminal lobe of TRIB1 exhibits most features common
to active kinases, and superimposes well with the C-terminal
lobes of AMP-regulated kinases from both yeast and humans,
CaMKII and Aurora kinases (Figure S1). The most striking
architectural differences in TRIB1 are within the N-terminal
lobe of the pseudokinase (Figures 1B and 1C). Most obviously,
TRIB1 contains a truncated, bent, aC helix that is severely dis-
torted from that seen in most bona fide protein kinases (Figures
1C and S1). This conformation means the TRIB1 aC helix fails to
form one wall of the nucleotide-binding pocket as it does in most
kinases that are capable of binding ATP (Figure 1C). We observe
a near-identical conformation of the aC helix in both crystal
structures of TRIB1, which have completely distinct lattice
arrangements. Thus, this aC-helix conformation is unlikely to
be caused by crystal packing. The aC helix is a commonly ex-
ploited device in the regulation of bona fide kinases, and has
been demonstrated to assume various conformational states in
non-activated kinases. Correct placement of the aC helix is
essential for formation of an intact regulatory hydrophobic spine,
a unifying feature of active kinases (Taylor and Kornev, 2011).
However, the truncated nature of the aC helix in TRIB1 means
that it is tightly tethered to the b3 strand. This makes it difficult
to envisage extension of the aC helix into a more conventional
state, or assembly of the regulatory spine, without deformation
of the b3 strand that sits above the ATP-binding pocket.
Another clear deficiency in Tribbles pseudokinases is a diver-
gent glycine-rich loop (linking b1 and b2), which should conven-
tionally sit above an occupied ATP-binding pocket. The three
Tribbles proteins are three residues shorter than conventional ki-
nases in this region and contain at least one proline residue near
the end of b1. TRIB1 contains the sequence PLAEREH in this
region. In the structure, Pro98 acts to prematurely terminate b1
and twist the strand toward b2 (Figure S2). This means that theAll rights reserved
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Figure 2. The Pseudoactive Site of TRIB1
(A) The hypothetical position of ATP (based on superposition with PDB: 1ATP)
is represented by transparent spheres, and the Glu-Ser-Leu-Glu-(Asp) motif at
the base of the TRIB1 activation loop is shown as sticks. Notable residues from
the TRIB1 pseudokinase domain that form polar contacts with the base of the
activation loop are indicated (orange sticks, orange labels), and residues that
form the hydrophobic pocket occupied by Leu226 are shown as yellow sticks.
(B) Detailed view of the gatekeeper region. Gatekeeper residues from various
kinase structures (pale blue transparent sticks) superimposed on the structure
of TRIB1. Structures usedwere from depositions PDB: 2h6d, 3dae, 3gfw, 3kl8,
4pds, and 3kk8. Phe160 and Leu226 from TRIB1 are shown as orange sticks.
(C) Normalized thermal-shift assays of TRIB1(84–343) in the presence of
increasing concentrations of ATP.
See also Figure S3.
Table 1. Crystallographic Data
TRIB1(84–343)
Iodide
Derivative TRIB1(84–343) TRIB1(84–372)
Wavelength (A˚) 1.5498 0.954 0.954
Resolution
(outer shell) (A˚)
48.58–3.29
(3.47–3.29)
48.5–2.80
(2.95–2.80)
42.90–2.10
(2.21–2.10)
Space group P6222 P6222 P63
Unit cell
parameters ()
a = b = 152.8 a = b = 152.7 a = b = 81.3
c = 63.0 c = 62.8 c = 85.8
a = b = 90 a = b = 90 a = b = 90
g = 120 g = 120 g = 120
Rsym (outer shell) 0.173 (1.240) 0.097 (1.025) 0.166 (1.303)
Rpim (outer shell) 0.066 (0.476) 0.046 (0.492) 0.035 (0.277)
Mean I/sI
(outer shell)
12.1 (2.8) 18.6 (2.0) 21.3 (3.2)
Completeness
(outer shell)
99.7 (98.1) 100.0 (100.0) 100.0 (100.0)
Multiplicity
(outer shell)
13.7 (13.5) 9.6 (9.9) 23.0 (23.0)
Total no. of
reflections
94,883
(13,047)
106,556
(15,650)
434,409
(62,970)
No. of unique
reflections
6,940 (963) 11,093
(1,586)
18,911
(2,743)
Mean (I) half-set
correlation CC1/2
0.988 (0.835) 0.999
(0.781)
0.999
(0.838)
Wilson B
factor (A˚2)
74.5 57.7 40.0
Refinement Statistics
Rcryst 0.207 (0.327) 0.176 (0.247)
Rfree 0.246 (0.403) 0.223 (0.265)
Rmsd for bonds (A˚) 0.008 0.010
Rmsd for angles () 1.38 1.39
Rmsd for chiral
volume (A˚3)
0.07 0.08
No. of protein atoms 1,919 2,062
No. of water atoms 0 107
Average main-chain
B factor (A˚2)
56.8 26.5
Average side-chain
B factor (A2)
64.8 32.2
Average water
B factor (A˚2)
NA 39.6
Ramachandran Plot Statistics (%)
Favored regions 94.3 95.9
Allowed regions 5.3 4.1
Outliers 0.4 0
PDB ID 5CEK 5CEM
Rmsd, root-mean-square deviation.loop between b1 and b2 of TRIB1 is notably retracted compared
with the elongated Gly-rich loop seen in active kinases (Fig-
ure 1C). Together with the truncated aC helix, the retracted
TRIB1 Gly-rich loop contributes to a wide opening rather than
a narrow deep ATP-binding pocket.Structure 23, 2111–21The Degenerate DFG Motif Prevents ATP Binding
Recent studies indicate that while nucleotide binding is only ex-
hibited by approximately one-third of pseudokinases, TRIB2 can
engage ATP very weakly, with an affinity in the millimolar range
(Bailey et al., 2015; Murphy et al., 2014b). The two structures
of TRIB1 presented herein exhibit near-identical ATP-binding
pockets, both of which are in a conformation that is, in contrast
to TRIB2, unlikely to bind nucleotides. This is due to the poorly
formed walls of the nucleotide-binding pocket discussed above,
but also occlusion of the ATP pocket by the degraded Asp-Phe-
Gly (DFG) motif at the base of the activation loop (Figure 2A).
Tribbles-type pseudokinases all harbor an unconventional
Ser-Leu-Glu (SLE) sequence in the position usually occupied
by the DFG motif, which normally completes the hydrophobic
regulatory spine and coordinates Mg2+ in conventional ki-
nases (Taylor and Kornev, 2011; Taylor et al., 2013). In TRIB1,
Leu226 from the SLE motif nestles into a pocket formed by
Phe122, Ile146, Val158, and Phe160 (yellow stick residues in Fig-
ure 2A). This position overlaps with the location occupied by the
so-called gatekeeper residue of active kinases (Figure 2B). The
gatekeeper residue is located adjacent to the nucleotide-binding
site and is a major determinant of the size of the ATP-binding
pocket and, thus, sensitivity to small-molecule inhibitors. The
predicted gatekeeper residue of TRIB1 (Phe160) is actually dis-
placed toward the hinge between the N- and C-terminal lobes.
Thus, rather than aligning with the regulatory spine, as would
the phenylalanine of a conventional DFG motif (Taylor and Kor-
nev, 2011), Leu226 sits in an adjacent position and stabilizes
an activation loop that occludes the nucleotide-binding pocket21, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2113
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B Figure 3. The TRIB1 Recognition Sequence
of C/EBPa
(A) GST pulldown of indicated C/EBPa frag-
ments expressed as His6-MBP fusion proteins
(Coomassie-stained SDS-PAGE). Input GST con-
trol and GST-TRIB1 are shown in the right-hand
panel, and C/EBPa fusion protein input lanes
represent 10% of input protein.
(B) GST pulldown of indicated sequential trunca-
tions of C/EBPa. Asterisk indicates non-specific
band co-purified with GST-TRIB1.
(C) GST pulldown of indicated C/EBPa mutants
by GST-TRIB1(84–343). Upper panels are Coo-
massie blue-stained reducing SDS-PAGE, while
below are western blots visualized using anti-His6
immunoblotting. Asterisk indicates a non-specific
band co-purified with GST-TRIB1.
(D) Alignment of C/EBPa TRIB1 recognition se-
quences from indicated species, colored accord-
ing to sequence similarity. Effects of mutagenesis
performed in (C) are indicated above, categorized
based on western blotting in the lower portion of
the panel.
(E) Schematic illustrating selective isoform recog-
nition of C/EBPa by TRIB1.(Figures 2A and S1B). Another interaction that stabilizes this
conformation of the SLEmotif is Lys120 from the b3 strand form-
ing a hydrogen bond with the backbone of Leu226. This lysine
would conventionally form a salt bridge with a glutamate from
the aC helix. However, in the structures reported here, the mal-
formed aC helix means that there is no candidate acidic residue
anywhere on the adjacent face of the aC helix.
The amino acid directly preceding the SLE motif in TRIB1 is a
glutamate (Glu224). In the structure, this residue forms hydrogen
bonds with backbone amides of both Leu226 and Asp228.
Intriguingly, analysis of all human protein kinases (compiled
from Manning et al., 2002) reveals that TRIB1, TRIB2, and
TRIB3 are unique in having an acidic residue preceding the
DFG position. Stabilizing Glu224 in this location is Lys210 from
the C-terminal portion of the catalytic loop. A lysine in this posi-
tion is also unusual among kinase domains, and in this case
Lys210 is held in place between polar interactions with the cata-
lytic aspartate residue (Asp205) and the backbone carbonyl of
Glu224. The complex network of interactions we observe in
two unique crystal forms suggests that occlusion of the ATP
pocket by the SLE motif represents a stable, inactive conforma-
tion. To verify this, we interrogated the ability of TRIB1 to bind
nucleotides in presence or absence of cations using a fluores-
cence-based thermal-shift assay (Murphy et al., 2014b). These
assays showed that either TRIB1(84–343) or TRIB1(84–372) did
not detectably bind ATP, ADP, AMP, or AMPPNP at 200 mMcon-
centration in the absence or presence of 1 mM MgCl2, or to the
promiscuous ATP-mimetic inhibitors, DAP and VI16832 (Figures
S3A–S3C). Because earlier work indicated that TRIB2 binds ATP
in a cation-independent manner (Bailey et al., 2015), we exam-
inedwhether TRIB1(84–343) or TRIB1(84–372) could accomplish
the same by performing a titration of ATP between concentra-
tions of 200 mM and 1 mM, but did not observe any measurable
conferral of thermal stability (Figures 2C and S3D, respectively).2114 Structure 23, 2111–2121, November 3, 2015 ª2015 Elsevier LtdThe TRIB1 Recruitment Sequence of C/EBPa
Having gained a clear understanding of the architecture of the
TRIB1 pseudoactive site, we sought to understand the basis
for specific recognition of C/EBPa by TRIB1. To this end we
expressed a panel of maltose-binding protein (MBP) fusion
proteins derived from different conserved regions of C/EBPa.
These fusion proteins were used as prey in glutathione S-trans-
ferase (GST)-pulldown experiments with GST-TRIB1(84–343).
Theminimal TRIB1 pseudokinase domain was able to selectively
bind C/EBPa(53–98), but showed no association with the other
conserved regions that were tested (Figure 3A).
To further define the Trib recognition sequence, we employed
a series of C/EBPa truncation mutants in GST pulldown experi-
ments. This revealed that the shortest conserved region of
C/EBPa that we tested (C/EBPa(53–75)) still retained the ability
to bind TRIB1 (Figure 3B). Of note, residues 53–75 are encom-
passed within one of two transactivation domains of C/EBPa,
which in early studies was identified as having an important
role in the stability of the protein (Pei and Shih, 1991).
To address which residues within the sequence are most
crucial for TRIB1 binding, we assayed C/EBP–TRIB1 associa-
tion following site-directed mutagenesis of conserved residues
within C/EBPa. A series of residues from throughout the region
tested (Ile55, Glu59, Ile62, Ile64, and Ile68) were sensitive to
mutation and had significantly diminished binding (Figure 3C).
All residues important for C/EBPa recognition are conserved
in homologs from various species (Figure 3D), including Slbo
from Drosophila, suggesting that Tribbles-based recognition of
C/EBP transcription factors is likely to be conserved throughout
Metazoa. Mutation of Tyr67 to phenylalanine had little effect
on TRIB1 binding, whereas C/EBPa Tyr67Ala bound markedly
less. This suggests that the bulky aromatic nature of this amino
acid is important for binding, while a large hydrophobic amino
acid (leucine) may be capable of playing this role in Slbo.All rights reserved
AC
D
E F
B
TRIB1(84–343)
TRIB1(84–343)
TRIB1(84–372)
TRIB1(84–372)
Figure 4. The COP1-Binding Motif Interacts
with the Modified aC Helix of TRIB1
(A) The C-terminal segment of TRIB1 is shown as
gray sticks, with surrounding 2Fo-Fc electron
density map (contoured to 1s) following final
refinement.
(B) The overall structure of the C-terminal tail
of TRIB1 relative to the core kinase domain. The
disordered linker connecting Leu342 and Ile357 is
indicated as a dotted line. See also Figure S4.
(C) Multiple sequence alignment of the COP1
binding motif across the three human Tribbles
proteins.
(D) Overlay of experimental scattering data (black
circles) and scattering profile calculated using
CRYSOL for the respective TRIB1 crystal struc-
tures (red). Agreement between the experimental
data and calculated scatter pattern is signified by
c = 0.401 and c = 0.882 for TRIB1(84–343) and
TRIB1(84–372), respectively. Guinier plot for each
respective dataset is shown inset, indicating that
aggregates do not measurably contribute to the
scattering profile.
(E) Interatomic distance distributions of TRIB1(84–
343) and (84–372), represented by orange squares
andgray triangles, respectively. Seealso FigureS5.
(F) Thermal-shift assays directly comparing
melting profiles of TRIB1(84–343) and (84–372).Surprisingly, the relatively conservative mutation of Ser61Ala
severely diminished C/EBPa binding, suggesting that this resi-
due is central to the interaction between TRIB1 and C/EBPa.
That C/EBPa(53–75) represents the region of C/EBPa recog-
nized by Tribbles proteins is entirely consistent with the previ-
ously reported effect of Tribbles overexpression. Expression of
Trib1 or Trib2 has been demonstrated to control the cellular bal-
ance between the p42 and p30 isoforms of C/EBPa, decreasing
levels of p42 but not p30 C/EBPa (Keeshan et al., 2006). Our data
suggest a clear reasonwhy the p30 isoform is impervious to Trib-
bles overexpression: because it begins at Met120, p30 does not
contain the Trib recognition sequence (Figure 3E).
Intramolecular Sequestration of theCOP1-BindingMotif
The COP1-binding motif is critical for TRIB1 to regulate levels of
C/EBPa (Akira et al., 2013; Dedhia et al., 2010), and is composed
of residues 355–360 (DQIVPE) within the C-terminal extension
of TRIB1. In our structure incorporating the full C-terminal tailStructure 23, 2111–2121, November 3, 2015 ªof TRIB1(84–372), clear electron den-
sity terminates at residue Leu342 of the
pseudokinase domain. However, there
is an obvious stretch of electron den-
sity in a groove between the b4 strand
and modified aC helix within the N-termi-
nal lobe of TRIB1. The resolution of the
diffraction data meant that this polypep-
tide sequence could be unambiguously
identified as residues 357–364, which in-
cludes most of the previously identified
COP1-binding motif of TRIB1 (Figure 4A).
This VPE motif is conserved among
Tribbles proteins, and lies at the heartof the interaction between the C-terminal extension and the
pseudokinase domain of TRIB1 (Figures 4B and 4C). The spe-
cific contacts include Glu360 forming polar interactions with
Tyr127 and Arg132 from the aC helix, and Val358 sitting in a
hydrophobic groove formed between Ile135 and Ile146 (from
aC and b4, respectively). These interactions facilitate extension
of the b sheet of the N-terminal lobe, through hydrogen bonds
between the b4 strand and backbone moieties of residues 359,
361, and 363. When comparing the docking surface on the
pseudokinase with and without the C-terminal tail, there is a
small shift (1.7 A˚) along the long axis of the bent aC helix,
along with several side chains shifting conformation to accom-
modate the C-terminal tail. The loop connecting aC and b4,
which contains His140, also becomes disordered upon
COP1-binding motif docking (Figure S4A). While differing crys-
tal packing makes it difficult to assign cause and effect to these
changes, they do illustrate that the aC helix has some degree of
mobility.2015 Elsevier Ltd All rights reserved 2115
Table 2. SAXS Parameters and Data Analyses
Data Collection Parameters
Instrument Australian
Synchrotron SAXS/
WAXS beamline
Beam geometry
wavelength (A˚)
120-mm point
source, 1.033
q range (A˚1)a 0.01397–0.400
Exposure time (s) 2
Temperature (C) 15
TRIB1(84–343) TRIB1(84–372)
Protein
concentration
3.64 mg/ml protein
via inline gel filtration
chromatography
6.65 mg/ml protein
via inline gel filtration
chromatography
Structural Parameters
I(0) (cm1)
(from P(r))
0.005147 ± 0.000118 0.01286 ± 0.000177
Rg (A˚) (from P(r)) 25.39 ± 0.68 29.11 ± 0.41
Dmax (A˚) 80 90
I(0) (cm1)
(from Guinier)
0.005135 ± 0.000151 0.012911 ± 0.000236
Rg (A˚) (from
Guinier)
24.68 ± 1.24 28.77 ± 0.66
Fit of monomer
crystal structure
to experimental
data (from
CRYSOL)
c = 0.401 with
PDB: 5CEK
c = 0.882 with
PDB: 5CEM
Software Employed
Primary data
reduction
Scatterbrain (Australian
Synchrotron)
Data processing PRIMUS, GNOM
Computation of
model intensities
CRYSOL
Porod-Debye
analysis
ScA˚tter
aq is the magnitude of the scattering vector, which is related to the scat-
tering angle (2q) and the wavelength (l) as follows: q = (4p/l)sinq.Docking to sites surrounding the aC helix is a commonly ex-
ploited mechanism of regulation for bona fide kinases (Taylor
and Kornev, 2011). For instance, the docking site for the C-termi-
nal COP1-binding motif on the pseudokinase domain does
bear a resemblance to that used by AGC family kinases. Binding
of the C-terminal sequence of AKT1 to stabilize its kinase do-
mains is one such example (Figure S4B) (Lippa et al., 2008).
However, the truncated nature of the TRIB1 aC helix means
that the interaction is significantly abbreviated compared with
AKT1. Compared with closer TRIB1 relatives from the CAMK
group of kinases, the docking site is also in a similar region to
docking of the C-terminal domain of the yeast AMPK homolog
(Snf1) to its core kinase domain, which has been proposed to
play an autoinhibitory role (Chen et al., 2009). However, this he-
lical domain binds closer to the C-terminal end of the helix and
does not form extensive contacts with the b4 strand. In essence,
docking of the C-terminal COP1-binding motif extends the
theme of regulatory docking through the aC helix, with unique2116 Structure 23, 2111–2121, November 3, 2015 ª2015 Elsevier Ltdvariation necessitated by the makeup of the TRIB1 N-terminal
domain.
To confirm whether the interaction we observe in the crystal
represents an intramolecular or intermolecular interaction, we
used size-exclusion chromatography coupled with multiple-
angle laser light scattering (SEC-MALLS). This revealed that
both TRIB1 constructs eluted as monomers when analyzed at
various concentrations up to 200 mM (Figure S5A), which agrees
with small-angle X-ray scattering (SAXS) analysis (see below).
Thus, in solution it is most probable that an intramolecular inter-
action occurs between one TRIB1 pseudokinase and its own
C-terminal tail.
Behavior of TRIB1 in Solution
To further interrogate the intramolecular sequestration of the
COP1-binding motif, we assessed the behavior of TRIB1 in
solution using SAXS. Data collected at the Australian Synchro-
tron SAXS/WAXS beamline were monodisperse, with no protein
aggregation evident from Guinier analyses, and Porod volumes
consistent with monomeric species (Figures 4D and 4E). Scat-
tering data for TRIB1(84–343) and TRIB1(84–372) each represent
a good fit with their respective crystal structures (c = 0.401 and
c = 0.882, respectively; Figures 4D and Table 2). The slightly
elevated c value for the TRIB1(84–372) construct is indicative
that there may be some level of heterogeneity that is not fully
captured by the crystal structure, which would be expected if
the C-terminal COP1-binding motif and its connecting linker
can adopt multiple conformations. Crucially, Pored-Debye anal-
ysis shows that both TRIB1(84–343) and TRIB1(84–372) are
equally compact (Figure S5B). This suggests that in solution
the C-terminal tail of TRIB1 associates with the core pseudoki-
nase domain, rather than drifting free in solution. While the over-
all shape and compactness of the two different TRIB1 constructs
are very similar, the interatomic distance distribution indicates
that TRIB1(84–372) has a maximum dimension 10 A˚ greater
than the core kinase domain (Figure 4E). This could be explained
by the extended C-terminal tail following the last residue defined
in the crystal structure (Asp364), which would be expected to
protrude even further from its observed position associated
with the N-terminal lobe.
To further examine the intramolecular association of the TRIB1
pseudokinase domain with its C-terminal tail, we also compared
the melting temperatures of TRIB1(84–343) and TRIB1(84–372)
using a thermal-shift assay (Figure 4F). TRIB1(84–372) had a
melting temperature 2.8C higher than TRIB1(84–343). This reit-
erates that the C-terminal region of TRIB1 increases the stability
of the core pseudokinase domain rather than existing free in
solution, and provides complementary evidence for the intramo-
lecular interaction between the C-terminal tail and TRIB1 pseu-
dokinase domain in solution.
Effect of the COP1-BindingMotif on C/EBP Recruitment
Binding studies and mutagenesis displayed in Figure 3 suggest
that the majority of C/EBP residues recognized by TRIB1 are
hydrophobic, with the notable exception of Glu59 and Ser61.
To survey potential interaction sites for C/EBP on TRIB1, we
thus mapped hydrophobicity of surface-exposed residues on
the structure of TRIB1(84–372) (Figure 5A). This analysis shows
a clear patch of hydrophobic residues on the rear surface ofAll rights reserved
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Figure 5. Effect of Intramolecular Recruit-
ment of the COP1-Binding Motif on C/EBPa
Binding
(A) Front and rear surface representations of
TRIB1(84–372) colored according to hydropho-
bicity (Kyte and Doolittle, 1982), generated using
Chimera (purple, least hydrophobic; yellow, most
hydrophobic). The C-terminal tail of TRIB1 is
shown as gray sticks. See also Figure S6.
(B) Representative isothermal titration calorimetry
of MBP-C/EBPa(53–75) injected into TRIB1(84–
343) (orange) and TRIB1(84–372) (gray). The heat of
dilution from ligand injection into buffer is displayed
in black. Error bars correspond to the estimated
error of individual integrated isotherm data points,
as calculated by NITPIC (Keller et al., 2012).
(C) Mean thermodynamic parameters from tripli-
cate ITC titrations after individual fitting using
SEDPHAT. The errors in KD reflect the SEM based
on three independent repeats of each measure-
ment. See also Figure S7.the pseudokinase opposite the degraded ATP-binding pocket,
which could constitute a C/EBP recruitment surface. In addition,
there is an enrichment of residues that diverge in TRIB3 but are
conserved in TRIB1 and TRIB2 on the rear surface of pseudoki-
nase (Figure S6). As described previously, Trib1 and Trib2, but
not Trib3, are able to interact with C/EBP proteins and regulate
their degradation by COP1 (Dedhia et al., 2010). The combina-
tion of crystallographic, SAXS, and thermal-shift data suggest
that the C-terminal COP1-binding motif associates with this
same surface of the TRIB1 pseudokinase domain. Therefore, it
appears possible that C/EBP recruitment and intramolecular as-
sociation of the COP1-binding motif could be linked.
One putative hypothesis is that interaction of the C-terminal
COP1-binding motif with the core pseudokinase domain of
TRIB1 could enhance recruitment of C/EBPs by creating an
additional binding surface for C/EBPs. An alternative is that
transient association of the COP1-binding motif with the pseu-
dokinase represents an inhibitory state, whereby the C-terminal
tail of TRIB1 and C/EBP binding may be competitive. To test
these alternatives, we compared the ability of TRIB1(84–343)
and TRIB1(84–372) to bind a fusion protein containing the C/
EBPa recognition sequence using isothermal titration calorim-
etry. We repeatedly observed tighter binding by the pseudoki-
nase alone relative to the extended form of TRIB1 in isothermal
titration calorimetry (ITC) experiments (7.2 mM compared with
11 mM; Figures 5B, 5C, and S7). Thesemoderate, but consistent,
differences in affinity clearly negate the hypothesis that the
C-terminal region of TRIB1 could enhance binding of C/EBP,
and suggest that the C-terminal region is subtly detrimental to
C/EBP binding.
Together, these findings suggest possible communication
between sequestration of the COP1-binding motif and recruit-
ment of C/EBP transcription factors. This may manifest as
the COP1-binding motif of TRIB1 weakly self-associating with
the pseudokinase domain, until such a time that it is disfavored
by substrate binding. Substrate binding and freedom of the
COP1-binding motif would then be coupled to allow conditional
formation of the active TRIB1-COP1 ubiquitination complex. An
equally plausible model is that binding of the C-terminal region ofStructure 23, 2111–21TRIB1 by COP1 sequesters the C-terminal motif from the pseu-
dokinase domain and allows for enhanced recruitment of C/EBP
substrates.
DISCUSSION
Pseudokinases comprise a significant proportion of the human
kinome and are found throughout the kingdoms of life (Bou-
deau et al., 2006; Murphy et al., 2014b). In broad terms they
either function as adapter proteins or allosterically activate other
enzymes, particularly other kinases. The clearest role of Tribbles
proteins is in the former category, as adapters that recruit
substrates for ubiquitination by the COP1 ubiquitin ligase. In
terms of overall structure, TRIB1 is remarkably conventional in
its C-terminal lobe and superimposes well with various active
kinases. The close structural homology of TRIB1with AMP-regu-
lated kinases is particularly intriguing given that Trib3 is reported
to regulate AMPK effectors AKT and acetyl-CoA carboxylase
(Du et al., 2003; Qi et al., 2006). The same cannot be said for
the N-terminal lobe, which deviates in two of themost character-
istic features of conventional kinases, the aC helix and Gly-
rich loop. The other major departure of Tribbles protein lies in
its DFG motif.
The DFG motif in most kinases is a key signature found at
the N-terminal base of the activation loop. In active kinases,
the aspartate within this motif coordinates magnesium to act
as a catalytic cofactor, and the phenylalanine residue forms
part of the hydrophobic regulatory spine of the kinase (Taylor
and Kornev, 2011). This active state is described as a ‘‘DFG-
in’’ state, as opposed to the ‘‘DFG-out’’ conformations observed
in inhibited kinases that have the phenylalanine residue pointing
away from the aC helix. The SLE sequence present in Tribbles
proteins deviates far from the norm in this regard, and the struc-
tures of TRIB1 that we have captured are clearly incompetent
with respect to ATP binding. More than just failing to substitute
for the DFG motif, it appears that the SLE in TRIB1 actively
contributes to occlusion of the ATP pocket. This is consistent
with our biochemical assays and unsuccessful attempts to
co-crystallize TRIB1 with ATP or soak ATP into TRIB1 crystals.21, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2117
Superficially, the interactions of the SLE motif are reminiscent of
the DFG-out autoinhibition mechanism observed in tyrosine
kinases of the insulin receptor family (Artim et al., 2012; Hub-
bard et al., 1994). However, TRIB1 takes this mechanism to
the extreme. Leu226 is buried deep in the N-terminal lobe, dis-
placing the putative gatekeeper residue. Moreover, Leu226 is
stabilized in this position by a complex network of interactions
involving both key catalytic residues (for example, the catalytic
aspartate and b3 lysine residues) and specific sequence adapta-
tions of Tribbles proteins.
It has recently been reported that TRIB2, the closest homolog of
TRIB1, is capable of weakly binding ATP in a cation-independent
manner (Bailey et al., 2015). While we cannot exclude differences
in structure between TRIB1 andTRIB2 (71% identical at the amino
acid level; Figure 1A), or that the SLE motif could take a different
form when bound to another protein in vivo, it is difficult to
envisage how this may lead to productive nucleotide binding in
TRIB1. Leu226 in TRIB1 would need to be repositioned toward
the aC helix to assume a more conventional active alignment of
the hydrophobic regulatory spine. However, such a rearrange-
ment into a canonical DFG-in position is sterically prevented by
Tyr134 from the aC helix. This offers a possible explanation for
the recent report that TRIB2 is able to bind nucleotides. Tyr134
is not conserved in TRIB2, where the equivalent residue is a
cysteine (Cys104) thatwould allowmore freedomof theSLEmotif.
The close association of Leu226 and the predicted gatekeeper
residue of TRIB1 (Phe160) is also relevant to the observation that
mutating the gatekeeper residue of TRIB2 (Phe130) can make it
sensitive to small-molecule inhibitors (Bailey et al., 2015): gate-
keeper mutation may also allow greater freedom of the SLE motif
to adopt different positions. Given that neither of our two crystal
structures show density between residues 229 and 237, one
outstanding question is whether the ‘‘activation loop’’ of Tribbles
proteins can also adopt a more ordered conformation in other cir-
cumstances. For instance, the effect of Thr229, which is reported
in Phosphosite as being a potential phosphorylation site, on the
stability of the activation loop remains to be determined.
The interaction observed between the COP1-binding motif
and pseudokinase domain of TRIB1 has not previously been
suggested, and it is intriguing that it involves one of the most
distinctive features of TRIB1, the deformed aC helix. This indi-
cates that malformation of the aC helix does not just represent
loss of kinase domain integrity, but a functional adaptation that
is likely to be important for Tribbles regulation. The intramolecu-
lar interaction is ostensibly in the region proposed to be a unique
binding site following solution of the first crystal structure of
a pseudokinase domain, that of VRK3 (Scheeff et al., 2009).
VRK3 has an extension at the C terminus of its aC helix, which
protrudes from the rear surface of the kinase domain. These
two examples show that the aC helix can be exploited for regu-
lation of both active and inactive kinase domains, and suggest
that if a kinase does not preserve the aC helix to frame catalysis,
it may afford an opportunity for greater sequence and structure
variation for ulterior purposes.
Our data exclude a model where binding of the C-terminal
COP1-bindingmotif by the pseudokinase enhancesC/EBPbind-
ing, but rather suggests that removing the C-terminal tail can
enhance binding. We propose that the moderate nature of the
observed difference is consistent with an allosteric effect, rather2118 Structure 23, 2111–2121, November 3, 2015 ª2015 Elsevier Ltdthan direct competition between the C-terminal COP1-binding
motif and C/EBP substrate for the same binding site. For
instance, stabilization of the N-terminal domain observed in Fig-
ure 4F may have the effect of antagonizing substrate binding.
Exactly how this cooperativity between substrate and COP1
binding could be manifested is a key outstanding question.
Release of a functionalmotif outside of the pseudokinase domain
is reminiscent of the recently proposed mechanism of the mixed
lineage kinase-like (MLKL) pseudokinase. Dislodging MLKL’s
N-terminal four-helix bundle from the pseudokinase domain
has recently been discovered as a key step during programmed
necrosis (Hildebrand et al., 2014). This release is triggered by
phosphorylation of the pseudokinase domain by RIPK3. Thus
far there is no evidence that TRIB1 acts a phosphorylation-sensi-
tive adapter, but this is a possibility worthy of future investigation.
CCAAT-enhancer binding proteins are a ubiquitous family
of transcription factors that recognize a characteristic cytosine-
cytosine-adenosine-adenosine-thymidine motif in promoter re-
gions. While C/EBP family members have overlapping targets,
differential effects are seen upon their expression, and different
members are required to act sequentially in developmental pro-
cesses. Overexpression of Trib1 or Trib2 in hematopoietic stem
cells, or bone marrow, specifically causes degradation of the
p42 but not the p30 isoform of C/EBPa (Dedhia et al., 2010; Kee-
shan et al., 2006). Identification of the TRIB1 recognition
sequence of C/EBP familymembers explains these observations
and is particularly relevant to AML progression. The truncated
(p30) isoform of C/EBPa induces a transformed phenotype in a
dominant-negative fashion, disrupting terminal differentiation
normally conferred by the full isoform (p42) (Calkhoven et al.,
2000). This imbalance in C/EBPa isoforms leads to the develop-
ment of AML. Up to 10%of AMLpatients harbormutations in one
or bothC/EBPa alleles. AMLpatients with biallelicC/EBPamuta-
tions generally have one N-terminal mutation and one C-terminal
mutation (Nerlov, 2004), and mutations that decrease the p42
isoform while preserving the p30 isoform are associated with
AML development (Leroy et al., 2005; Pabst et al., 2001). In
contrast, patients with biallelic mutations have a significantly
better overall and disease-free survival (Wouters et al., 2009),
suggesting that eliminating C/EBPa entirely is more favorable
than having imbalanced levels of the two isoforms. Both TRIB1
and TRIB2 are overexpressed in different subsets of AML pa-
tients (Keeshan et al., 2006; Storlazzi et al., 2004). This indicates
that perturbing C/EBPa levels either through direct mutation
or by modulation of TRIB1 or TRIB2 levels can drive AML, and
strongly suggests that preventing Tribbles proteins from degrad-
ing C/EBPa p42 would be therapeutically beneficial. Intriguingly,
it has recently been suggested that TRIB2 is susceptible to
binding small-molecule inhibitors (Bailey et al., 2015). The work
presented here lays a platform for future studies investigating
these potential small-molecule inhibitors, and characterizing
their effect on substrate recruitment by Tribbles proteins and
the intact Tribbles-COP1 E3 ligase complex.EXPERIMENTAL PROCEDURES
Protein Expression and Purification, and GST Pulldowns
All proteins were expressed inEscherichia coliBL21(DE3). For crystallization, a
codon optimized gene encoding human TRIB1 was synthesized and clonedAll rights reserved
into a modified pET-LIC vector (kindly gifted by the Netherlands Cancer
Institute Protein Facility with funding from grant no. 175.010.2007.012), incor-
porating an N-terminal 6xHis tag and 3C protease cleavage site. All experi-
ments involving Trib(84–372) contained a Cys372Ser mutation to avoid
erroneous disulfide formation in vitro. TRIB1 proteins (both 84–343 and
84–372) were initially purified by Ni2+ affinity chromatography, and purified
to homogeneity after cleavage with 3C protease using anion exchange
(Resource Q) and size-exclusion (Superdex-75 or Superdex-200, respectively)
chromatography. Isolated proteins and complexes were flash-frozen for stor-
age in 10 mM HEPES (pH 7.6), 300 mM NaCl, and 2 mM DTT.
For GST pulldown assays, C/EBP gene fragments were synthesized with
reduced GC content to improve PCR amplification, inserted into a LIC-modi-
fied His-MBP fusion expression vector, and purified by Ni2+ affinity chroma-
tography. GST-TRIB1 was expressed from a LIC-modified pGEX vector, and
purified using glutathione Sepharose. GST-TRIB1 and respective His-MBP-
C/EBP fragments were incubated together in 50 mM Tris (pH 8.0), 300 mM
NaCl, 2 mM DTT, and 0.2% (v/v) Tween 20, and washed with an identical
buffer. Following separation using SDS-PAGE (10%–20% acrylamide Tris-
glycine gradient gels), proteins were visualized using Coomassie brilliant
blue staining and/or immunoblotting using an anti-His6 primary antibody (Qia-
gen) and an anti-mouse secondary antibody labeled with LICOR IR800 dye. All
mutagenesis was performed using QuikChange site-directed mutagenesis.
Crystallization and Structure Determination
TRIB1(84–343) was initially crystallized in 0.1M Bis-Tris (pH 5.5) and 3MNaCl.
Poor initial diffraction was improved through seeding and additive screening,
with final data collected from crystals grown in 0.1 M Bis-Tris (pH 5.5),
2–3 M NaCl, 0.1 M sodium citrate, 0.01 M reduced L-glutathione, and
0.01 M oxidized L-glutathione. Crystals were frozen in mother liquor supple-
mentedwith 25%glycerol. The structure was solved by SIRAS using autoRick-
shaw and 3.4-A˚ data from a sodium iodide-soaked crystal of TRIB1(84–343),
with native data to 2.9 A˚ (Panjikar et al., 2005). Both datasets used to solve
the structure were collected at the MX2 beamline at the Australian Syn-
chrotron. The model was subsequently refined against native data to 2.8 A˚
collected at the MX1 beamline. All diffraction data were processed using
XDS followed by AIMLESS, refinement performed using REFMAC, and itera-
tive rebuilding in Coot (Emsley and Cowtan, 2004; Kabsch, 2010; Murshudov
et al., 2011). Cycles of refinement were also performed using the PDBredoweb
server (Joosten et al., 2014).
TRIB1(84–372) was crystallized from a 12-mg/ml complex mixture also
containing the reported TRIB1 interactor, MAP2K6. The two proteins were ex-
pressed separately and initially purified using affinity chromatography before
being mixed at an approximately 1:1 ratio and co-eluted from S200 size-exclu-
sion chromatography, although not as an apparent heterodimer. The protein
mixture was concentrated before establishing crystallization trials. Size-exclu-
sion chromatography was performed in a buffer containing 10 mM HEPES
(pH 7.6), 100 mM NaCl, and 2 mM DTT. A single TRIB1 crystal grew from a
sitting drop containing 250 nl of protein mixed with 200 nl of 1.0 M ammonium
sulfate, 0.1 M Bis-Tris (pH 5.5), and 1% (w/v) polyethylene glycol 3350.
The crystal was cryoprotected in mother liquor supplemented with 25% glyc-
erol, and data were collected at the MX1 beamline at the Australian Synchro-
tron. The structure was solved by molecular replacement in Phaser with
TRIB1(84–343) as a search model (Storoni et al., 2004). Electron density corre-
sponding to the C-terminal COP1 binding motif (residues 357–364) was clearly
visible following molecular replacement with the experimentally phased
TRIB1(84–343) structure. Structural figures were prepared using PyMol and
Chimera (Pettersen et al., 2004), and sequence alignment figures generated
using Aline (Bond and Schu¨ttelkopf, 2009).
Small-Angle X-Ray Scattering
SAXS data collection was performed at the Australian Synchrotron SAXS/
WAXSbeamline (Kirby et al., 2013) using an inline gel filtration chromatography
setup, essentially as described previously (Carr et al., 2014; Kershaw et al.,
2013; Murphy et al., 2013, 2014a; Varghese et al., 2014). Summary statistics
for data collection and analysis are reported in Table 2. 50 ml of purified recom-
binant TRIB1(84–343) at 3.65 mg/ml or TRIB1(84–372) at 6.64 mg/ml was
injected onto an inline Superdex 200 5/150 column (GE Healthcare) and eluted
at a flow rate of 0.2 ml/min via a 1.5-mm glass capillary positioned in the X-rayStructure 23, 2111–21beam in 500 mM NaCl, 10 mM HEPES (pH 7.5), 5% (v/v) glycerol, and 0.2 mM
tris(2-carboxyethyl)phosphine (TCEP) at 15C. Scattering data were collected
in 2-s exposures over the course of the elution and 2D intensity plots with
consistent scatter intensities from the peak of the size-exclusion chromatog-
raphy run were radially averaged and normalized to sample transmission,
with background subtraction performed using Scatterbrain software (Stephen
Mudie, Australian Synchrotron). Background scatter was assessed by aver-
aging scattering profiles from earlier in the size-exclusion chromatography
run, prior to protein elution. Guinier analysis of each scatter pattern across
the single elution peak showed consistent radius of gyration (Rg) values, and
superimposable patterns were averaged. A total of 11 and 7 scatter profiles
from the apex of the TRIB1 84–343 and 84–372 elution peaks, respectively,
were averaged and background subtracted using Scatterbrain to generate
the averaged scatter patterns presented in Figure 5. Guinier analysis of data
was performed using PRIMUS (Konarev et al., 2003) and indirect Fourier trans-
form with GNOM (Svergun, 1992) to obtain the distance distribution function,
P(r), and the maximum dimension, Dmax, of the scattering particle. CRYSOL
(Svergun et al., 1995) was used to calculate theoretical scattering curves
from crystal structure atomic coordinates and compare these with experi-
mental scattering curves. ScA˚tter was used for Porod-Debye analysis (Rambo
and Tainer, 2011).
SEC-MALLS
SEC-MALLS was carried out using a Wyatt Dawn 8+ detector (Wyatt Technol-
ogy) coupled to a Superdex-200 (10/300) column and refractive index detec-
tor. Samples were run in 10 mM HEPES (pH 7.6), 500 mM NaCl, 5% glycerol,
and 0.2 mM TCEP at the indicated concentrations. All data were analyzed
using ASTRA V software.
Thermal-Shift Assays
Thermal-shift assays were performed as described previously (Murphy et al.,
2013, 2014a, 2014b), using a Rotor-Gene Q PCR. TRIB1(84–343) or TRIB1(84–
372) was diluted in 150 mM NaCl, 20 mM Tris (pH 8.0), and 1 mM DTT to
2.5 mM final concentration, and assayed with the appropriate concentration of
nucleotide in a total reaction volume of 25 ml. SYPROOrange (Molecular Probes)
was used as a fluorescence probe and detected at 530 nm. For the ATP titration
experiment, ATP concentrationswere varied to achieve 0–1mMfinal concentra-
tion. Data shown are representative of two independent experiments.
Isothermal Titration Calorimetry
ITC experiments were performed at 30C using a VP-ITC (GE Healthcare).
TRIB1 and various C/EBP peptides fused to MBP were purified by Ni2+ affinity
chromatography and size-exclusion chromatography, and dialyzed into a
matched buffer consisting of 20 mM HEPES (pH 7.6), 300 mM NaCl,
0.25 mM TCEP, and 5% glycerol. C/EBP (563 mM) was injected into 22.5 mM
TRIB1(84–343) or 25 mM TRIB1(84–372).
Baseline corrections and integration were performed using NITPIC (Keller
et al., 2012), isotherms were fit to a single site-binding model using SEDPHAT
(Houtman et al., 2007), and figures were generated using GUSSI (http://
biophysics.swmed.edu/MBR/software.html).
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